Short report: Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 3, 2009, Pages 387-389

  Soto, Jaime ^a   Rea, Jaime ^b   Valderrama, Margarita ^b   Toledo, Julia ^a   Valda, Luis ^c   Ardiles, Jaime ^c   Berman, Jonathan ^d  

^a Centro de Investigaciones Bioclinicas de la Fundación FADER   (Colombia)

^b Proyecto Proyecto Obras Sociales de Caminos de Acceso Rur   (Bolivia)

^c Hosp Clin   (Bolivia)

^d Fast Track Drugs and Biologics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE; ANTIPROTOZOAL AGENT; DRUG DERIVATIVE; PHOSPHORYLCHOLINE;

ADULT; ARTICLE; BOLIVIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LEISHMANIASIS; MALE; MUCOSAL LEISHMANIASIS; RELAPSE; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING; CLINICAL TRIAL; DRUG ADMINISTRATION; SKIN LEISHMANIASIS;

ADULT; ANTIPROTOZOAL AGENTS; BOLIVIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; PHOSPHORYLCHOLINE;

EID: 69249171287     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.81.387     Document Type: Article

References (7)

1. Soto J, Toledo J, Valda L, Balderrama M, Rea I, Parra R, Ardiles J, Soto P, Gomez A, Molleda F, Fuentelsaz C, Anders G, Sindermann H, Engel J, Berman J, 2007. Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis 44: 350-356. (Pubitemid 46147616)
2. Franke ED, Llanos-Cuentas A, Echevarria J, Cruz ME, Campos P, Tovar AA, Lucas CM, Berman JD, 1994. Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis. Am J Trop Med Hyg 51: 77-82. (Pubitemid 24266291)
3. Llanos-Cuentas A, Echevaria J, Cruz M, La Rosa A, Campos M, Franke E, Berman J, Modabber F, Marr J, 1997. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis. Clin Infect Dis 25: 677-684. (Pubitemid 27392612)
4. Romero GA, Lessa HA, Orge MG, Macêdo VO, Marsden PD, 1998. Treatment of mucosal leishmaniasis with aminosidine sulfate: results of two year follow up. Rev Soc Bras Med Trop 31: 511-516.
5. Dorlo TP, van Thiel PP, Huitema AD, Keizer RJ, de Vries HJ, Beijnen JH, de Vries PJ, 2008. Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients. Antimicrob Agents Chemother 52: 2855-2860.
6. Oliveira-Neto MP, Mattos M, Pirmez C, de Sousa CFS, Junior GG, 2000. Mucosal leishmaniasis (espundia) responsive to low dose of n-methyl glucamine (glucantime) in Rio de Janeiro, Brazil. Rev Inst Med Trop São Paulo 42: 321-325. (Pubitemid 32057363)
7. Machado PR, Lessa H, Lessa M, Guimarães LH, Bang H, Ho JL, Carvalho EM, 2007. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis 44: 788-793. (Pubitemid 46365302)